Broadview Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Broadview Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$5.3M	Buy	+53,500	New	+$5.11M	1.64%	29

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Broadview Advisors's PRAH Position: Q2 2019 in Review

Broadview Advisors opened a new position in PRA Health Sciences, Inc. (PRAH) in Q2 2019: 53,500 shares worth $5.3M. The stake represents 1.64% of the portfolio and ranks #29 among its holdings.

329 funds tracked by Wall St. Rank hold PRAH as of Q2 2019.

Broadview Advisors held 53,500 shares of PRA Health Sciences, Inc. worth $5.3M as of Q2 2019.
PRA Health Sciences, Inc. was a new Broadview Advisors position in Q2 2019.
PRA Health Sciences, Inc. made up 1.64% of Broadview Advisors's portfolio in Q2 2019, its #29 holding.
329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2019.

Based on Broadview Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.